Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-2 of 2
Keywords: drug development
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2017) 474 (10): 1559–1577.
Published: 26 April 2017
...). Conversely, RPV- and EFV-resistant strains were fully sensitive to DOR. Nowadays, CADD is widely applied to the rationalization and speeding up of the drug development process, starting from the promising hits obtained by high-throughput enzymatic assays or virtual screening approaches of libraries...
Articles
Post-translational import of protein into the endoplasmic reticulum of a trypanosome: an in vitro system for discovery of anti-trypanosomal chemical entities
Available to PurchaseBhargavi Patham, Josh Duffy, Ariel Lane, Richard C. Davis, Peter Wipf, Sheara W. Fewell, Jeffrey L. Brodsky, Kojo Mensa-Wilmot
Journal:
Biochemical Journal
Biochem J (2009) 419 (2): 507–517.
Published: 27 March 2009
... chemical entities’ (e.g. MAL3-101, equisetin and CJ-21,058) for anti-trypanosome drug development. 1 These authors contributed equally to this work. 2 Present address: Department of Medical Education, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, 5001 El...